×
About 9,626 results

ALLMedicine™ Leukemias Center

Research & Reviews  4,561 results

Second Report of PDE10A-BRAF Fusion in Pediatric Spindle Cell Sarcoma With Infantile Fi...
https://doi.org/10.1177/10935266211012186
Pediatric and Developmental Pathology : the Official Jour... Hughes CE, Correa H et. al.

Jun 14th, 2021 - Infantile/congenital fibrosarcoma (IFS) is the most common soft tissue tumor in children less than one year of age. The most common anatomic site of IFS is in the extremities or trunk, and rarely in the abdomen or retroperitoneum. Approximately 70...

AXL inhibition in macrophages stimulates host-versus-leukemia immunity and eradicates n...
https://doi.org/10.1158/2159-8290.CD-20-1378
Cancer Discovery; Tirado-Gonzalez I, Descot A et. al.

Jun 9th, 2021 - Acute leukemias are systemic malignancies associated with a dire outcome. Due to low immunogenicity, leukemias display a remarkable ability to evade immune control and are often resistant to checkpoint blockade. Here, we discover that leukemia cel...

Enhancer hijacking drives oncogenic BCL11B expression in lineage ambiguous stem cell le...
https://doi.org/10.1158/2159-8290.CD-21-0145
Cancer Discovery; Montefiori LE, Bendig S et. al.

Jun 9th, 2021 - Lineage ambiguous leukemias are high-risk malignancies of poorly understood genetic basis. Here, we describe a distinct subgroup of acute leukemia with expression of myeloid, T lymphoid and stem cell markers driven by aberrant allele-specific dere...

Current Status of CAR T Cell Therapy for Leukemias.
https://doi.org/10.1007/s11864-021-00859-8 10.3322/caac.21551 10.1002/cncr.30791 10.1056/NEJMra1400972 10.1002/cncr.30003 10.1016/j.critrevonc.2016.12.004 10.1126/scitranslmed.3008226 10.1056/NEJMoa1215134 10.1016/S0140-6736(14)61403-3 10.1056/NEJMoa1709866 10.1158/1078-0432.CCR-18-2035 10.1080/10428194.2019.1691201 10.1182/blood-2019-129279 10.1182/blood-2019-130983 10.1182/bloodadvances.2020003092 10.1182/blood-2020-136674 10.1038/nm.3838 10.1016/j.ccell.2015.09.004 10.1016/S2352-3026(20)30277-5 10.1182/blood-2020-134472 10.1056/NEJMoa1709919 10.1038/s41375-020-0792-2 10.1182/blood-2015-08-665547 10.1158/2159-8290.CD-15-1020 10.1182/blood-2012-06-438002 10.1038/nm.4441 10.1200/JCO.19.03279 10.1182/blood-2019-129411 10.1158/1538-7445.Am2020-ct051 10.1182/blood-2014-10-551895 10.1007/s11899-019-00501-3 10.1186/s13045-019-0801-y 10.1016/j.beha.2019.101097 10.1182/blood-2018-10-882944 10.1038/nm.4444 10.1002/ajh.24794 10.1172/JCI94306 10.3389/fonc.2019.00126 10.1182/blood-2015-02-629527 10.1182/blood-2017-01-761320 10.1038/s41375-018-0065-5 10.1182/blood-2017-09-797712 10.1089/hum.2017.241 10.1182/blood-2018-99-110579 10.1182/blood-2020-134930 10.1182/blood-2012-12-474056 10.1182/blood.V130.Suppl_1.811.811 10.1182/blood.V130.Suppl_1.1359.1359 10.3389/fonc.2020.00697 10.1172/JCI84813 10.1016/j.ymthe.2017.01.011 10.1182/blood-2004-11-4564 10.1182/blood-2017-02-769208 10.1158/1538-7445.Am2018-1631 10.1126/scitranslmed.aad5222 10.1182/blood-2014-01-552174 10.1038/nm.4241 10.1182/blood-2015-11-683847 10.1016/j.omtm.2019.11.018 10.1182/blood-2018-99-117493 10.1002/ijc.33212 10.1158/1078-0432.CCR-15-1527 10.1038/s41375-017-0008-6 10.3389/fimmu.2019.02664 10.1038/s41591-018-0146-z 10.1038/mt.2014.164 10.1002/ajh.25235 10.1038/s41375-020-0831-z 10.1200/JCO.2019.37.15_suppl.7006 10.1056/NEJMoa1407222 10.1182/blood.2019001641 10.1182/blood.V128.22.218.218 10.1172/JCI85309
Current Treatment Options in Oncology; Harris K, LaBelle JL et. al.

Jun 7th, 2021 - Chimeric antigen receptor (CAR) T-cell therapy has become the standard of care for children and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia (B-ALL), and it is a highly promising therapy under investigation for adu...

see more →

Guidelines  19 results

Acute Myeloid Leukemia - AML | ARUPConsult Lab Test Selection
https://arupconsult.com/content/acute-myeloid-leukemia

Jun 30th, 2019 - Acute myeloid leukemias (AMLs) are a heterogeneous group of disorders characterized by the clonal expansion of myeloid blasts (eg, undifferentiated myeloid precursors) in the peripheral blood, bone marrow, and/or other tissues, which results in im...

Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/6/article-p721.xml
Journal of the National Comprehensive Cancer Network;

Jun 14th, 2019 - Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for ...

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
https://www.gotoper.com/conferences/hem/meetings/23rd-international-congress-on-hematologic-malignancies-focus-on-leukemias-lymphomas-and-myeloma

Feb 27th, 2019 - Now in its 23rd year, the annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma provides practitioners who manage hematologic malignancies the practical tools to translate emerging data into the bes...

Hematology Quality Metrics
http://www.hematology.org/Clinicians/Guidelines-Quality/503.aspx
Allen, S.

Feb 20th, 2018 - These clinical performance measures are designed for individual quality improvement. Some of the measures may also be appropriate for accountability if appropriate sample sizes and implementation rules are achieved.

see more →

Drugs  39 results see all →

Clinicaltrials.gov  4,761 results

Second Report of PDE10A-BRAF Fusion in Pediatric Spindle Cell Sarcoma With Infantile Fi...
https://doi.org/10.1177/10935266211012186
Pediatric and Developmental Pathology : the Official Jour... Hughes CE, Correa H et. al.

Jun 14th, 2021 - Infantile/congenital fibrosarcoma (IFS) is the most common soft tissue tumor in children less than one year of age. The most common anatomic site of IFS is in the extremities or trunk, and rarely in the abdomen or retroperitoneum. Approximately 70...

AXL inhibition in macrophages stimulates host-versus-leukemia immunity and eradicates n...
https://doi.org/10.1158/2159-8290.CD-20-1378
Cancer Discovery; Tirado-Gonzalez I, Descot A et. al.

Jun 9th, 2021 - Acute leukemias are systemic malignancies associated with a dire outcome. Due to low immunogenicity, leukemias display a remarkable ability to evade immune control and are often resistant to checkpoint blockade. Here, we discover that leukemia cel...

Enhancer hijacking drives oncogenic BCL11B expression in lineage ambiguous stem cell le...
https://doi.org/10.1158/2159-8290.CD-21-0145
Cancer Discovery; Montefiori LE, Bendig S et. al.

Jun 9th, 2021 - Lineage ambiguous leukemias are high-risk malignancies of poorly understood genetic basis. Here, we describe a distinct subgroup of acute leukemia with expression of myeloid, T lymphoid and stem cell markers driven by aberrant allele-specific dere...

Current Status of CAR T Cell Therapy for Leukemias.
https://doi.org/10.1007/s11864-021-00859-8 10.3322/caac.21551 10.1002/cncr.30791 10.1056/NEJMra1400972 10.1002/cncr.30003 10.1016/j.critrevonc.2016.12.004 10.1126/scitranslmed.3008226 10.1056/NEJMoa1215134 10.1016/S0140-6736(14)61403-3 10.1056/NEJMoa1709866 10.1158/1078-0432.CCR-18-2035 10.1080/10428194.2019.1691201 10.1182/blood-2019-129279 10.1182/blood-2019-130983 10.1182/bloodadvances.2020003092 10.1182/blood-2020-136674 10.1038/nm.3838 10.1016/j.ccell.2015.09.004 10.1016/S2352-3026(20)30277-5 10.1182/blood-2020-134472 10.1056/NEJMoa1709919 10.1038/s41375-020-0792-2 10.1182/blood-2015-08-665547 10.1158/2159-8290.CD-15-1020 10.1182/blood-2012-06-438002 10.1038/nm.4441 10.1200/JCO.19.03279 10.1182/blood-2019-129411 10.1158/1538-7445.Am2020-ct051 10.1182/blood-2014-10-551895 10.1007/s11899-019-00501-3 10.1186/s13045-019-0801-y 10.1016/j.beha.2019.101097 10.1182/blood-2018-10-882944 10.1038/nm.4444 10.1002/ajh.24794 10.1172/JCI94306 10.3389/fonc.2019.00126 10.1182/blood-2015-02-629527 10.1182/blood-2017-01-761320 10.1038/s41375-018-0065-5 10.1182/blood-2017-09-797712 10.1089/hum.2017.241 10.1182/blood-2018-99-110579 10.1182/blood-2020-134930 10.1182/blood-2012-12-474056 10.1182/blood.V130.Suppl_1.811.811 10.1182/blood.V130.Suppl_1.1359.1359 10.3389/fonc.2020.00697 10.1172/JCI84813 10.1016/j.ymthe.2017.01.011 10.1182/blood-2004-11-4564 10.1182/blood-2017-02-769208 10.1158/1538-7445.Am2018-1631 10.1126/scitranslmed.aad5222 10.1182/blood-2014-01-552174 10.1038/nm.4241 10.1182/blood-2015-11-683847 10.1016/j.omtm.2019.11.018 10.1182/blood-2018-99-117493 10.1002/ijc.33212 10.1158/1078-0432.CCR-15-1527 10.1038/s41375-017-0008-6 10.3389/fimmu.2019.02664 10.1038/s41591-018-0146-z 10.1038/mt.2014.164 10.1002/ajh.25235 10.1038/s41375-020-0831-z 10.1200/JCO.2019.37.15_suppl.7006 10.1056/NEJMoa1407222 10.1182/blood.2019001641 10.1182/blood.V128.22.218.218 10.1172/JCI85309
Current Treatment Options in Oncology; Harris K, LaBelle JL et. al.

Jun 7th, 2021 - Chimeric antigen receptor (CAR) T-cell therapy has become the standard of care for children and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia (B-ALL), and it is a highly promising therapy under investigation for adu...

see more →

News  245 results

The Next 'Big Thing' for Blood Cancers Featured at ASH 2019
https://www.staging.medscape.com/viewarticle/921942

Dec 6th, 2019 - The prospect of an "off-the-shelf" product, rather than one that needs to be grown individually for each patient, is a "very exciting" proposition, say experts discussing new data that will be presented at the forthcoming American Society of Hemat...

The Next 'Big Thing' for Blood Cancers Featured at ASH 2019
https://www.medscape.com/viewarticle/921942

Dec 6th, 2019 - The prospect of an "off-the-shelf" product, rather than one that needs to be grown individually for each patient, is a "very exciting" proposition, say experts discussing new data that will be presented at the forthcoming American Society of Hemat...

Federal Health Care Cancer Data Trends 2019
https://www.mdedge.com/fedprac/article/209596/federal-health-care-cancer-data-trends-2019?channel=167

Oct 7th, 2019 - Click here to access Federal Health Care Cancer Data Trends 2019 Table of Contents Introduction Cancer in the VA: The Big Picture Hepatocellular Carcinoma Prostate Cancer Multiple Myeloma Lung Cancer in the VA at a National Level Lung Cancer – Reg.

Leukemia Federal Health Care Data Trends
https://www.mdedge.com/fedprac/avaho/article/208837/oncology/leukemia-federal-health-care-data-trends?channel=263
Joao L. Ascensao, MD, PhD, FACP

Sep 25th, 2019 - (function(n){var r="_ion_ionizer",t=n. getElementsByTagName("script"),i;t=t[t.

see more →

Patient Education  1 results see all →